Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Japan Tobacco Inc (2914) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9900
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, prescription drugs and generic drugs. The company supplies the products to supermarkets, convenience stores, street and train station kiosks, small independent retailers and vending machines. JT Group caters to retail, industrial and commercial customers in Japan, Europe, CIS, Africa, the Middle East, Asia and Americas and other regions. The company manufactures its products in its own facilities in Japan and other countries. JT Group is headquartered in Tokyo, Japan.

Japan Tobacco Inc (2914) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Japan Tobacco, Torii Pharmac and Sumitomo Dainippon Pharma Enter into Partnership 10
Japan Tobacco Enters into Agreement with Torii Pharma 11
Japan Tobacco Enters Into Co-Marketing Agreement With Torii Pharma For JTK-303 12
Licensing Agreements 13
ROHTO Pharma Enters into Licensing Agreement with Japan Tobacco 13
Torii Pharma Enters into Licensing Agreement with Japan Tobacco 14
Japan Tobacco Enters into Licensing Agreement with EirGen Pharma 15
Japan Tobacco Enter into Licensing Agreement with Torii Pharmaceutical 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 18
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 19
Asset Transactions 20
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 20
Japan Tobacco Inc – Key Competitors 21
Japan Tobacco Inc – Key Employees 22
Japan Tobacco Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Clinical Trials 26
Jan 12, 2018: Top-line Results of the Topical JTE-052 JAK Inhibitor Phase 3 Clinical Study (Comparative Study) in Japan 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Japan Tobacco, Torii Pharmac and Sumitomo Dainippon Pharma Enter into Partnership 10
Japan Tobacco Enters into Agreement with Torii Pharma 11
Japan Tobacco Enters Into Co-Marketing Agreement With Torii Pharma For JTK-303 12
ROHTO Pharma Enters into Licensing Agreement with Japan Tobacco 13
Torii Pharma Enters into Licensing Agreement with Japan Tobacco 14
Japan Tobacco Enters into Licensing Agreement with EirGen Pharma 15
Japan Tobacco Enter into Licensing Agreement with Torii Pharmaceutical 16
JW Pharma Enters into Licensing Agreement with Japan Tobacco 17
Leo Pharma Enters into Licensing Agreement with Japan Tobacco for JTE-052 18
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 19
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 20
Japan Tobacco Inc, Key Competitors 21
Japan Tobacco Inc, Key Employees 22
Japan Tobacco Inc, Subsidiaries 24

List of Figures
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Japan Tobacco Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VWR International LLC-製薬・医療分野:企業M&A・提携分析
    Summary VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, b …
  • Nanosphere Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Hyundai Motor Company:企業の戦略・SWOT・財務分析
    Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report Summary Hyundai Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-P …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Columbus McKinnon Corp (CMCO):企業の財務・戦略的SWOT分析
    Summary Columbus McKinnon Corp (CMCO) is an industrial equipment company that offers cranes and hoists. The company designs, manufactures and markets material handling systems and services, which are used for moving, lifting, positioning and securing materials. Its products include hoists, actuators …
  • Oman Telecommunications Company SAOG:企業の戦略・SWOT・財務情報
    Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report Summary Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務情報
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ingram Micro Inc.:企業の戦略的SWOT分析
    Ingram Micro Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cavco Industries Inc:企業の戦略・SWOT・財務情報
    Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Resilux NV:企業の戦略・SWOT・財務情報
    Resilux NV - Strategy, SWOT and Corporate Finance Report Summary Resilux NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MAEC-Kazatomprom LLP:企業の戦略的SWOT分析
    MAEC-Kazatomprom LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • Volkswagen AG (VOW3)-エネルギー分野:企業M&A・提携分析
    Summary Volkswagen AG (Volkswagen) is an automobile company involved in the design, development, production and sales of a wide range of vehicles and engines. It commercializes both passenger and commercial vehicles, including low consumption small cars and luxury class vehicles. The company sells i …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Providence Resources plc (PZQA):企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Regulus Therapeutics Inc (RGLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Swiss Re Group:企業のM&A・事業提携・投資動向
    Swiss Re Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Re Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Indianapolis Power & Light Co:発電所・企業SWOT分析
    Indianapolis Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆